Key facts
- President Trump launched a $700 million Regenerative Pilot Program.
- The program aims to help farmers adopt practices that improve soil health and productivity.
- The initiative is part of the "Make America Healthy Again" strategy.
- Health insurers are aligning with the "Make America Healthy Again" movement.
- Insurers are launching plans targeting chronic disease, AI, and functional medicine.
- This strategy may help insurers avoid scrutiny over rising healthcare costs.
- Doctors' groups oppose the health insurers' alignment with MAHA.
- MAHA activists feel betrayed by a Supreme Court ruling.
- The Supreme Court ruled Monsanto does not need to label Roundup with a cancer warning.
- The Trump administration backed Monsanto in the Supreme Court case.
- The ruling could strain the movement's ties with the Republican Party.
President Trump has initiated a new $700 million Regenerative Pilot Program designed to support American farmers in adopting practices that enhance soil health and long-term agricultural productivity. This program is a component of the larger "Make America Healthy Again" strategy. Concurrently, health insurers are aligning with the "Make America Healthy Again" (MAHA) movement by introducing new plans. These plans focus on areas such as chronic disease management, artificial intelligence in healthcare, and functional medicine. This alignment may serve as a strategy for insurers to avoid increased scrutiny regarding rising healthcare costs. However, doctors' groups have voiced opposition to these developments. In a separate but related concern for the movement, prominent MAHA activists have expressed significant outrage and a feeling of betrayal following a Supreme Court ruling. The ruling favored Monsanto, determining that the company is not required to label its Roundup weedkiller with a cancer warning. The Trump administration supported Monsanto in this case. This decision could potentially weaken the relationship between the MAHA movement and the Republican Party.